COMMUNIQUÉS West-GlobeNewswire

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products

14/04/2025 - 14:00

Action delays to January 1, 2026, the effective date of a Biden-era Medicare LCD for skin substitute products used to treat diabetic foot ulcers and venous leg ulcers FLORHAM PARK, N.J., April 14, 2025 (GLOBE NEWSWIRE [...]

Can-Fite Reports 2024 Financial Results and Clinical Update

14/04/2025 - 14:00

Cancer-Free Survival of 8 Years in Liver Cancer Patient Treated with Namodenoson in Prior Phase II Study RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), [...]

Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs

14/04/2025 - 14:03

PITTSBURGH, Pa. & GAITHERSBURG, Md., April 14, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and healthy aging through technologically innovative and [...]

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

14/04/2025 - 14:15

New offering provides strategic guidance and AI-enabled biosimulation to navigate FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. ( [...]

Happy Go Leafy Offers 20% Off on Its Red Vein Kratom Collection This Easter!

14/04/2025 - 14:30

Happy Go Leafy announces a limited-time Easter offer! Get 20% off on all red vein kratom items from April 14-20, 2025, with code RELAX20. Miami, Florida, April 14, 2025 (GLOBE NEWSWIRE) -- Happy Go Leafy, a pioneer in [...]

Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships

14/04/2025 - 14:30

Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and [...]

Clene to Present at the Emerging Growth Conference

14/04/2025 - 14:30

SALT LAKE CITY, April 14, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]

UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025

14/04/2025 - 14:41

Data to be presented on Monday, April 28, 2025 CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today [...]

Transactions in Connection with Share Buy-back Program

14/04/2025 - 14:42

Company Announcement COPENHAGEN, Denmark; April 14, 2025 – Genmab A/S (Nasdaq: GMAB). On March 25, 2025, Genmab announced the initiation of a share buy-back program to repurchase up to 2.2 million shares to reduce [...]

Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer

14/04/2025 - 14:55

Tarapchak brings more than 30 years of accounting and finance expertise to the role CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading [...]

Regional Health Properties Reports Fourth Quarter & Full Year 2024 Financial Results

14/04/2025 - 15:00

ATLANTA, GA, April 14, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPB) (OTCQB: RHEPA), a self-managed healthcare real estate [...]

NeuroOne® OneRF® Technology Success Story Featured on Fox News

14/04/2025 - 15:00

Pediatric Patient Treated with OneRF ® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (" [...]

VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma

14/04/2025 - 15:00

— Innovative ethanol-free formulation intended to provide improved safety and advance care for patients undergoing high-dose conditioning therapy prior to autologous hematopoietic cell transplantation (AHCT) — First [...]

Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month

14/04/2025 - 15:00

26 USOSM Surgeon Partners to Participate Across Seven States IRVING, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- In honor of Oral, Head and Neck Cancer Awareness Month, 26 U.S. Oral Surgery Management surgeon partners in [...]

Transactions under Novonesis’ share buyback program

14/04/2025 - 10:26

Please read the announcement in PDF Attachment 2025_18_Share_buyback_program

New Guideline Aims to Transform Obesity Care for Children and Adolescents

14/04/2025 - 06:01

First Canadian update in nearly 20 years prioritizes improvements in health and quality of life over weight loss outcomes EDMONTON, Alberta, April 14, 2025 (GLOBE NEWSWIRE) -- Healthcare providers and families have a [...]

Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US

14/04/2025 - 07:00

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Company aims to accelerate access to much-needed biosimilar to reference medicine Enbrel® * for US patients with disabling inflammatory diseases [...]

Press release: CMS Proposes Approval of Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases

14/04/2025 - 07:00

CMS Proposes Approval of Additional Payment for Sequana Medical’s alfapump® system in Hospital Inpatient Cases New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2026 Rule, expected to be finalized in [...]

European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy

14/04/2025 - 07:00

Approval based on Phase III STARGLO study where Columvi in combination with chemotherapy showed a 41% reduction in the risk of death compared to MabThera/Rituxan plus chemotherapy 1,2 DLBCL is an aggressive cancer with [...]